Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Shaker

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2026
Feed the Good Wolf: Motivational Interviewing, Cognitive Behavioral Therapy, and MindsetMarylee Verdi, Juliette Madan, Dominic Candido, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 18, 2021
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in CanadaElissa M Abrams, Matthew Greenhawt, Marcus Shaker, et al.
JAMA Network Open|October 24, 2019
Simulation of Health and Economic Benefits of Extended Observation of Resolved AnaphylaxisMarcus Shaker, Dana Wallace, David B K Golden, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 11, 2025
Risk managers for the risk managersSarah A Taylor-Black, Giselle Mosnaim, Aikaterini Anagnostou, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 19, 2019
Estimation of Health and Economic Benefits of Clinic Versus Home Administration of Omalizumab and MepolizumabMarcus Shaker, Aaron Briggs, Ahmad Dbouk, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 3, 2024
Balancing benefits and potential harms of stock inhaler policies in schoolsAlexandra E Conway, Marylee Verdi, John Oppenheimer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2021
The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to GoElissa M Abrams, Matthew Greenhawt, Waleed Alqurashi, et al.
Current Opinion in Pediatrics|February 15, 2021
Ten tips for improving your clinical practice during the COVID-19 pandemicElissa M Abrams, Alexander G Singer, Matthew Greenhawt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2018
Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literatureMarcus Shaker, Dana Toy, Christopher Lindholm, et al.
The Lancet. Respiratory Medicine|March 15, 2021
Treatment of mild-to-moderate asthma in childhood and adolescence in 2021Elissa M Abrams, Marcus Shaker, Matthew Greenhawt, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2026
Feed the Good Wolf: Motivational Interviewing, Cognitive Behavioral Therapy, and MindsetMarylee Verdi, Juliette Madan, Dominic Candido, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 18, 2021
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in CanadaElissa M Abrams, Matthew Greenhawt, Marcus Shaker, et al.
JAMA Network Open|October 24, 2019
Simulation of Health and Economic Benefits of Extended Observation of Resolved AnaphylaxisMarcus Shaker, Dana Wallace, David B K Golden, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 11, 2025
Risk managers for the risk managersSarah A Taylor-Black, Giselle Mosnaim, Aikaterini Anagnostou, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 19, 2019
Estimation of Health and Economic Benefits of Clinic Versus Home Administration of Omalizumab and MepolizumabMarcus Shaker, Aaron Briggs, Ahmad Dbouk, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 3, 2024
Balancing benefits and potential harms of stock inhaler policies in schoolsAlexandra E Conway, Marylee Verdi, John Oppenheimer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2021
The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to GoElissa M Abrams, Matthew Greenhawt, Waleed Alqurashi, et al.
Current Opinion in Pediatrics|February 15, 2021
Ten tips for improving your clinical practice during the COVID-19 pandemicElissa M Abrams, Alexander G Singer, Matthew Greenhawt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2018
Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literatureMarcus Shaker, Dana Toy, Christopher Lindholm, et al.
The Lancet. Respiratory Medicine|March 15, 2021
Treatment of mild-to-moderate asthma in childhood and adolescence in 2021Elissa M Abrams, Marcus Shaker, Matthew Greenhawt, et al.
Pageof 19